Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Accured Expenses: 2013-2024

Historic Change in Accured Expenses for Collegium Pharmaceutical (COLL) over the last 12 years, with Dec 2024 value amounting to -$39.5 million.

  • Collegium Pharmaceutical's Change in Accured Expenses rose 87.11% to -$8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 103.91%. This contributed to the annual value of -$39.5 million for FY2024, which is 6394.59% down from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Change in Accured Expenses of -$39.5 million as of FY2024, which was down 6,394.59% from $628,000 recorded in FY2023.
  • In the past 5 years, Collegium Pharmaceutical's Change in Accured Expenses registered a high of $4.8 million during FY2021, and its lowest value of -$39.5 million during FY2024.
  • Moreover, its 3-year median value for Change in Accured Expenses was -$11.1 million (2022), whereas its average is -$16.7 million.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first skyrocketed by 160.95% in 2021, then tumbled by 6,394.59% in 2024.
  • Over the past 5 years, Collegium Pharmaceutical's Change in Accured Expenses (Yearly) stood at -$7.8 million in 2020, then skyrocketed by 160.95% to $4.8 million in 2021, then tumbled by 333.01% to -$11.1 million in 2022, then spiked by 105.64% to $628,000 in 2023, then slumped by 6,394.59% to -$39.5 million in 2024.